RIVM_Logo_Engels

Immunogenicity and safety of a hexavalent meningococcal outermembrane-vesicle vaccine in children of 2-3 and 7-8 years of age

 

Home / Documents and publications / Immunogenicity and safety of a hexavalent meningococcal outermembrane-vesicle vaccine in children of 2-3 and 7-8 years of age

RIVM Committed to health and sustainability
Menu